Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research

The increasing prevalence of allergic diseases demands efficient therapeutic strategies for their mitigation. Allergen-specific immunotherapy (AIT) is the only causal rather than symptomatic treatment method available for allergy. Currently, AIT is being administered using immune response modifiers...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Litty Johnson, Albert Duschl, Martin Himly
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2020-05-01
Edice:	Vaccines
Témata:	AIT allergy alum calcium phosphate microcrystalline tyrosine CpG oligonucleotide
On-line přístup:	https://www.mdpi.com/2076-393X/8/2/237
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!